Curing blood cancers: rapid translation from target to drug to clinic [ 2018 - ]

Research Grant

Researchers: A/Pr David Curtis (Principal investigator)

Brief description Cure rates for many blood cancers have not improved over the last 20 years. We will use patient samples and mouse models of blood cancers to identify and test novel therapies. In particular, we will test the efficacy of a new drug developed by my laboratory in conjunction with a large team of Australian chemists. In collaboration with MERCK, this work will be the prelude to the first human trials in 2018. If successful, this will provide new hope for cure of a broad range of blood cancers.

Funding Amount $640,210.00

Funding Scheme Research Fellowships

Notes Research Fellowship